homocysteine has been researched along with liraglutide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Feng, M; Ji, J; Niu, X; Wang, Y; Zhang, X | 1 |
1 other study(ies) available for homocysteine and liraglutide
Article | Year |
---|---|
Liraglutide blocks the proliferation, migration and phenotypic switching of Homocysteine (Hcy)-induced vascular smooth muscle cells (VSMCs) by suppressing proprotein convertase subtilisin kexin9 (PCSK9)/ low-density lipoprotein receptor (LDLR).
Topics: Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Down-Regulation; Gene Expression Regulation; Homocysteine; Humans; Liraglutide; Mice; Muscle, Smooth, Vascular; Phenotype; Proprotein Convertase 9; Receptors, LDL | 2021 |